---
schema_version: "secwatch.filing_event.v1"
accession: "0001069530-22-000063"
form_type: "8-K"
ticker: "FLNA"
cik: "0001069530"
company_name: "FILANA THERAPEUTICS, INC."
filed_at: "2022-12-22T23:59:59+00:00"
generated_at: "2026-06-20T23:49:36.473573+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Cassava Sciences amends bylaws to fix board size at six members

## Summary
- Board amended Article II(1) of bylaws to set board size at six directors, effective Dec 19, 2022.
- Board size previously not fixed; change made by Board approval without shareholder vote.
- Certificate of Amendment filed as Exhibit 3.1 to this 8-K.

## SEC filing metadata
- accession: 0001069530-22-000063
- form_type: 8-K
- ticker: FLNA
- cik: 0001069530
- company_name: FILANA THERAPEUTICS, INC.
- filed_at: 2022-12-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069530/000106953022000063/0001069530-22-000063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069530/000106953022000063/sava-20221219x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001069530-22-000063
- JSON: https://secwatch.observer/filing/0001069530-22-000063.json
- Plain text: https://secwatch.observer/filing/0001069530-22-000063.txt

## Key facts
- Governance Changes
  FILANA THERAPEUTICS, INC.: Amended Article II(1) of Amended and Restated Bylaws to fix board size to six members (effective 2022-12-19).
  - Change: bylaw amendment
  - Effective: 2022-12-19
  source text: On December 19, 2022, the Board of Directors of Cassava Sciences, Inc. amended Article II(1) of its Amended and Restated Bylaws to fix the size of the board to six members, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069530/000106953022000063/0001069530-22-000063-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.